Systemic lupus erythematosus (SLE) is the most common type of lupus, a chronic autoimmune disease. Symptoms include fatigue, joint pain, and rashes across your nose and cheeks. While there’s no ...

Stanford's Structured Liberal Education (SLE) program has faced scrutiny over its focus on the Western canon, prompting discussions on diversity within its curriculum.

However, they stress that non-pharmacological options should not replace drug therapy when it is required, and refer readers to the full management recommendations for SLE and SSc.

The Food and Drug Administration (FDA) has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus (SLE) with extrarenal involvement. The FDA’s ...

Patient 4 with SLE, who had a rebound of proteinuria 4 months after CAR T-cell therapy and in whom follow-up renal biopsy did not reveal any histopathological signs of lupus nephritis (but ...

The Food and Drug Administration (FDA) has granted Fast Track designation to IMPT-514, a bispecific CD19/CD20-targeting chimeric antigen receptor (CAR) T-cell therapy for the treatment of active ...